# The Val-CARD Trial

> **NCT03825250** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Leicester** · enrollment: 122 (estimated)

## Conditions studied

- Cardiac Valve Disease
- Coronary Artery Disease
- Organ Failure, Multiple

## Interventions

- **DRUG:** Sodium Valproate

## Key facts

- **NCT ID:** NCT03825250
- **Lead sponsor:** University of Leicester
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-06
- **Primary completion:** 2024-10-07
- **Final completion:** 2024-10-07
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03825250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03825250, "The Val-CARD Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03825250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*